Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06169371
Title Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) (BRE-09)
Acronym BRE-09
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University of Illinois at Chicago
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.